Antacids Market by Type and Geography - Forecast and Analysis 2022-2026

The antacids market share is expected to increase to USD 712.45 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 3.37%.

This antacids market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers antacids market segmentation by type (non-symmetric antacids and symmetric antacids) and geography (North America, Europe, Asia, and Rest of World (ROW)).

What will the Antacids Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Antacids Market Size for the Forecast Period and Other Important Statistics

 

The antacids market report also offers information on several market vendors, including Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., iNova Pharmaceuticals, Johnson and Johnson, Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., United Natural Foods Inc., WellSpring Pharmaceutical Corp., and The Procter and Gamble Co. among others.

Parent Market Analysis

Technavio categorizes the global antacid market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the antacids market during the forecast period.

Who are the Major Antacids Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Advance Pharmaceutical Inc.
• AmerisourceBergen Corp.
• Bayer AG
• Cardinal Health Inc.
• GlaxoSmithKline Plc
• Humco Holding Group Inc.
• iNova Pharmaceuticals
• Johnson and Johnson
• Neogen Corp.
• Novartis AG
• NuCare Laboratories India
• Pfizer Inc.
• Pharmaceutical Associates Inc.
• Sanofi SA
• Sun Pharmaceutical Industries Ltd.
• United Natural Foods Inc.
• WellSpring Pharmaceutical Corp.
• The Procter and Gamble Co.

 

This statistical study of the antacids market encompasses successful business strategies deployed by the key vendors. The antacids market is fragmented and the vendors are deploying growth strategies such as R and D and technological innovation to compete in the market.

Product Insights and News

• AmerisourceBergen Corp. - The company offers antacids that are naturally made water dissolving formula to cure acidity and heartburn, under the brand name of American Health Packaging.
• AmerisourceBergen Corp. - Under the pharmaceutical distribution services segment, the company offers various products including pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and related equipment and services to various healthcare providers.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The antacids market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Antacids Market: Key Drivers, Trends, and Challenges

The rising geriatric population is notably driving the antacids market growth, although factors such as adverse effect of prolonged use of antacids may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the antacids industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Antacids Market Driver

One of the key factors driving the global antacids market growth is the rising geriatric population. With age, the sphincter in the lower esophagus tends to relax, which allows acid to reflux or flow backward, causing heartburn. Heartburn can also be caused by GERD. Age is directly related to the increase in various disorders, including GERD. Furthermore, advances in healthcare and advanced treatment options for various diseases have increased the average life expectancy of people. For instance, as per the US census bureau, in 2015, people aged 65 years and above were approximately 617 million, and the number is expected to reach 1,566 million by 2050. As per data collected by the World Bank and the NIH, the percentage of the aging population is expected to grow from 8.48% in 2016 to approximately 17% by 2050. Thus, such factors are expected to drive market growth in the forecast period.

Key Antacids Market Trend

Growing e-commerce market is one of the key antacids market trends that is expected to impact the industry positively in the forecast period. The global antacids market sees an increasing trend of online transactions as the market is dominated by OTC drugs that require no prescription. The major reason for the increased popularity of e-commerce retailing has been the retailers' efforts on improving the online shopping experience through better online education and targeted marketing. The strong viability of e-commerce channels further stimulates the sales of antacids. Online retailers also offer free access to various online offers. For instance, Amazon offers the option of different billing and shipping addresses, which helps the customer to send medication needed to a different geographic location easily. Such online facilities encourage consumers to buy medicines online, thereby stimulating market growth.

Key Antacids Market Challenge

One of the key challenges to the global antacids market growth is the adverse effect of prolonged use of antacids. Many antacids such as Maalox, Mylanta, Rolaids, and TUMS contain calcium. If these are taken in high doses, patients could be at risk of calcium overdose, which can lead to adverse effects such as nausea, kidney stones, and swelling of the feet. Antacids that consist of aluminum hydroxide may cause constipation, aluminum intoxication, osteocalcin, and hypophosphatemia. The availability of OTC antacids and their combined use with other medications can result in drug-drug interactions and have serious side effects. For instance, antacids, when taken with acidic drugs such as digoxin or chlorpromazine, can result in drug absorption due to which the concentration of the drug in the blood becomes low, which further reduces the efficacy of the drug. Such adverse effects of antacids can hamper the growth of the market.

This antacids market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Which are the Key Regions for Antacids Market?

For more insights on the market share of various regions Request for a FREE sample now!

41% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for antacids in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The high prevalence of GERD for which antacids are predominantly used, the increasing preference for OTC medications, and the practice of self-medication among the population will facilitate the antacids market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

Countries across North America were severely affected by the COVID-19 pandemic in 2020. The rise in the incidence of COVID-19 in countries across North America influenced governments to introduce emergency legislation, which included restrictions on several business activities. This led to the shutdown of manufacturing units of several industries. In the first few months of 2020, most pharmaceutical companies focused on developing vaccines and manufacturing drugs to support the medical crisis associated with COVID-19, reducing the production volume of antacids. This resulted in the slow growth of the market in North America. However, to support the sale of nonprescription or OTC drugs in March 2020, the American President, Joe Biden, signed the Coronavirus Aid Relief and Economic Security (CARES) Act (HR 748). Other factors such as the rising R and D expenditure by pharmaceutical companies in 2021 are expected to positively influence the antacids market growth in North America during the forecast period.

Antacids Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the antacids market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

What are the Revenue-generating Type Segments in the Antacids Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The antacids market share growth by the non-systemic antacid segment will be significant during the forecast period. The non-systemic antacids segment is expected to grow at a moderate rate in the coming years owing to better efficacy demonstrated when used in combination. In addition, the drugs used as combination therapies minimize the adverse effects and effectively treat GERD and acid reflux.

This report provides an accurate prediction of the contribution of all the segments to the growth of the antacids market size and actionable market insights on post COVID-19 impact on each segment.

 

Antacids Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 3.37%
Market growth 2022-2026	$ 712.45 million
Market structure	Fragmented
YoY growth (%)	3.11
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 41%
Key consumer countries	US, Canada, Brazil, Germany, and UK
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., iNova Pharmaceuticals, Johnson and Johnson, Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., United Natural Foods Inc., WellSpring Pharmaceutical Corp., and The Procter and Gamble Co.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Antacids Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive antacids market growth during the next five years
• Precise estimation of the antacids market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the antacids industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of antacids market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch